Amarin reported $-62832000 in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
DBV Technologies DBVT:US -23823000 7.05M
Abbvie ABBV:US $ 3295M 1422M
Aerie Pharmaceuticals AERI:US $ -18.14M 15.51M
Alnylam Pharmaceuticals ALNY:US $ -191.69M 44.95M
Amarin AMRN:US $ -62.83M 34.52M
AstraZeneca AZN:LN 44.27B 22.58B
Biocryst Pharmaceuticals BCRX:US $ -34.72M 15.24M
Epizyme EPZM:US $ -29806000 21.12M
Esperion Therapeutics ESPR:US $ -52376000 9.39M
GlaxoSmithKline GSK:LN 108.1B 121.2B
Halozyme Therapeutics HALO:US $ 34.06M 41.61M
Heron Therapeutics HRTX:US $ -49.5M 13.42M
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
IONIS PHARMACEUT IONS:US $ -85.51M 28.01M
JAZZ PHA JAZZ:US $ 85.55M 2M
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Neurocrine Biosciences NBIX:US $ -15.3M 18.4M
Novartis NOVN:VX 2.23B 624M
Teva Pharmaceutical Industries TEVA:US $ -949M 236M